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Original Article
Approaches to the measurement of masculinity encom-
pass a range from the proposing prescriptive and proscrip-
tive social norms that are distinct from gender identity 
(Thompson, Pleck, & Ferrera, 1992) to a normative per-
spective where cultural traditions and social practices are 
seen as shaping and shaped by socially constructed mas-
culinities and gender ideals (Connell & Messerschmidt, 
2005). Extending this narrative, Thompson and Bennett 
(2015) suggested that once internalized, these gender ide-
als become individualized belief systems about masculin-
ity, that is masculine beliefs. The importance for men’s 
health, then, is that these belief systems may help or hin-
der men’s health-promoting practices, wherein accurately 
mapping men’s health and illness behaviors with valid and 
responsive measurement is crucial (Luyt, 2015).
In terms of health, chronic disease in particular is 
known to be associated with masculinity, wherein soci-
etal constructions of masculinity can hinder health 
behaviors but in turn, chronic disease can impinge nega-
tively on personal perceptions of masculinity (Zanchetta 
et al., 2017). Until the work of Chambers et al. (2016), 
who developed the Masculinity in Chronic Disease 
Inventory (MCD-I), no validated measures existed that 
tapped into internalized masculine beliefs applicable to 
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Abstract
The Masculinity in Chronic Disease Inventory (MCD-I) is a new measure of internalized masculine beliefs previously 
validated in the context of prostate cancer. The present study assessed the validity of the MCD-I in men with other 
chronic diseases to explore its potential for wider application. A cross-sectional survey of 633 men aged 47–93 years 
old (M = 68 years), of whom 68% reported ≥2 chronic conditions, was conducted. Measures included the MCD-I and 
Erectile Function. Exploratory and confirmatory factor analyses were performed followed by tests for discriminant 
validity. A five-factor structure was confirmed that explained 60% of the variance, with good to excellent reliabilities 
(α = 0.68–0.93) for the domains of Optimistic Action, Sexual Importance/Priority, Family Responsibilities, Emotional 
Self-Reliance, and Strength/Fitness. The MCD-I is a valid measure of internalized masculine beliefs for men with 
chronic disease that appears sensitive to age and to sexual health. The tailoring of health services for men can be 
guided by MCD-I outcomes to ensure gender-sensitized men’s health interventions.
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researching chronic diseases. Importantly, the MCD-I 
was derived from a specific qualitative examination 
of men’s self-reported experiences of prostate cancer, 
thereby ensuring the items and constructs within the 
scale were relevant to the health, cultural, and social 
context of these men. Emergent scale domains included 
Strength, Sexual Importance/Priority, Emotional Self-
Reliance, Optimistic Capacity, Family Responsibilities 
and Action Approach. Further, these domains fit well 
within the theoretical lens of socially constructed mascu-
linities. In this germinal study, the MCD-I demonstrated 
good convergent, divergent, and discriminant validity, 
with excellent reliabilities.
However, as this instrument was developed and tested 
with a population of men who had been diagnosed with 
prostate cancer, it is important to broaden the scope of the 
measure to access conceptions of masculinity that are not 
tied to a single diagnostic group. For example, Chan and 
Corvin (2016) conducted a qualitative investigation find-
ing links between masculinity, depression, and chronic 
diseases such as cardiovascular disease, diabetes, and 
hypertension, finding a complex interplay of contextual 
factors. Of particular interest in a broader chronic disease 
population is the role of sexual identity in masculinity. 
Sexual Importance/Priority emerged as a separate factor 
in the sample of Chambers et al. (2016), and this is con-
sonant with the elevated potential for erectile dysfunction 
in prostate cancer treatment. Yet sexual difficulties and in 
particular erectile dysfunction are associated with a vari-
ety of chronic conditions in men (e.g., Sutsunbuloglu and 
Vural, 2018). Many different factors have been shown to 
affect men’s conceptions of erectile dysfunction and also 
the role of sexual difficulties in constraining, or not, con-
ceptions of masculinity (Thompson and Barnes, 2013; 
Wentzell, 2014). It is necessary to examine both the 
nature of sexual importance and its association with erec-
tile dysfunction in contexts beyond that of prostate 
cancer.
Accordingly, to further assess the utility of the MCD-I, 
the present study addresses the validity of the instrument 
in a large sample of men with a wide range of chronic 
diseases. Although it could be expected that a similar fac-
tor structure would emerge as for the original prostate 
sample, the present study included both exploratory and 
confirmatory analyses to allow the most appropriate 
structure for the broader population. With this approach, 
the MCD-I items were not constrained to the structure 
determined by previous empirical analyses but rather the 
factor structure was determined directly by initial analy-
ses with the present population. Validation techniques 
were included to mitigate against overfitting and sample-
specific associations. In view of the centrality of erectile 
dysfunction, the ability of the instrument to discriminate 
with respect to this variable was assessed.
Method
Participants and Procedure
Data for the present study were drawn from the Florey 
Adelaide Male Ageing Study (FAMAS), a prospective 
cohort of randomly-selected, community-dwelling mid-
dle-aged to elderly men, extensively characterized, 
including information on chronic disease status. Details 
of the broader study are reported elsewhere (Martin, 
Haren, Middleton, & Wittert, 2007). Written informed 
consent was obtained by all participants. Ethical approval 
for the study was obtained from the Royal Adelaide 
Hospital Research Ethics committee and, where appro-
priate, the Aboriginal Health Research Ethics Committee 
of South Australia (protocol number 020305). The proj-
ect is currently funded by NHMRC project grants 
(#1122342; #627227), with previous funding from the 
South Australian Premier’s Science and Research Fund 
and The University of Adelaide’s Florey Foundation. 
Data collected through the 2015 annual follow-up survey 
for 633 men were utilized (response rate: 68.7% of eligi-
ble participants).
Measures
MCD-I. The 22-item MCD-I was administered to all 
participants. Participants indicated on a 5-point Likert 
type scale how true each of the statements were for 
them, from 1 = not true at all to 5 = very true. The 
scale included six subscales representing different 
aspects of masculinity: Strength (five items), Sexual 
Importance/Priority (four items), Family Responsibili-
ties (four items), Emotional Self-Reliance (two items), 
Optimistic Capacity (four items), and Action Approach 
(three items). Higher subscales scores and total scores 
indicated stronger respondent endorsement of these 
masculine ideals.
Erectile function. Erectile function was measured with a 
single self-report item: “Impotence means being unable 
to get and keep an erection that is rigid enough for satis-
factory sexual activity. How would you describe your-
self?” Participants answered on a scale of 1 to 5, from 
1 = always able to get and keep an erection good enough 
for sexual intercourse to 4 = never able to get and keep 
an erection good enough for sexual intercourse (men who 
preferred not to answer could respond with 5 = refused to 
answer).
Covariate data. Men reported their age, relationship and 
family status, sexuality, education, employment status, 
and presence of chronic disease. Chronic disease status 
was collected as the patient’s recall of having ever been 
diagnosed by a physician (i.e., Have you ever been told 
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by a doctor that you have any of the following condi-
tions?) with any of the conditions presented in a list. 
Body mass index (BMI) was collected through a previous 
clinic visit.
Statistical Analysis
The structure of the MCDI was examined using a two-
part strategy. As the model was to be assessed in a new 
population to that in which it was developed, the sample 
was split randomly into two equal subsamples. Model 
development was conducted on one subsample and then 
assessed via confirmatory techniques in the other. First, 
exploratory factor analysis (EFA) via a minimum residual 
approach with promax rotation was used to examine the 
possible factor structure in one half of the sample. The 
potential number of factors was examined with Velicer’s 
Minimum Average Partial (MAP; Velicer, 1976). Second, 
confirmatory factor analysis (CFA) was used to test the fit 
of the suggested covariance structure in the second, hold-
out sample. Estimation was by robust maximum likeli-
hood in order to reduce the effects of the severe skew 
present in the data. As recommended by contemporary 
methodologists (Hu & Bentler, 1999; Kline, 2015), fit 
was assessed with the robust variants of chi-square, root 
mean square error of approximation (RMSEA), compara-
tive fit index (CFI), and standardized root mean square 
residual (SRMR). EFA was conducted using tools in the 
psych package (Revelle, 2018) and CFA analyses were 
conducted using the lavaan package (Rosseel, 2012).
Internal consistency reliability for each scale was 
assessed with Cronbach’s α. Discriminant validity was 
assessed using Pearson’s r. Of the 633 men whose 
responses were available, 11 had missed all 22 items of 
the MCD-I and were dropped from further analyses. The 
EFA was conducted with the 278 men in the first sub-
sample who had completed all MCD-I items. The CFAs 
were conducted with the 311 men in the second subsam-
ple who had provided some responses on the MCD-I. For 
erectile function, refusal to answer was treated as a miss-
ing response. All correlation analyses were conducted 
with all available participants. All analyses were con-
ducted with R 3.51. Statistical significance was taken as 
α = 0.05.
Results
Participants
Participants ages ranged from 47 to 93 years old (M = 68, 
SD = 10). The majority of the participants were exclu-
sively heterosexual (n = 501, 81%), married or in a de 
facto relationship (n = 498, 80%), and had children 
(n = 480, 77%). Most of the men had a high school 
education, apprentice or university qualifications (n = 
427, 69%) and indicated they were retired at the time of 
the questionnaire (n = 314, 51%; see Table 1). A large 
proportion of the participants were overweight (n = 267, 
43%) or obese (n = 199, 32%; class 1–3). Most men had 
comorbid chronic conditions, with 68% (n = 422) indi-
cating they had two or more chronic conditions, the most 
commonly reported being: hypertension (n = 301, 48%), 
hypercholesterolemia (n = 250, 40%), osteoarthritis 
(n = 171, 28%), enlarged prostate/benign prostatic 
hyperplasia (n = 118, 19%), and diabetes (n = 97, 16%). 
Twenty-three percent of participants indicated they had 
been diagnosed with one or more cancers, the most com-
mon diagnoses were skin cancer or melanoma (n = 111, 
18%) and prostate cancer (n = 47, 8%; see Table 2).
Exploratory Factor Analysis
Inspection of the MAP plots suggested that between four 
and five factors may have been present in the data. 
Although these were fewer than the six factors observed 
by Chambers et al. (2016), both solutions were examined 
further. The five-factor solution (see Table 3) accounted 
for 57% of the variance. The factors were named 
Optimistic Action, Sexual Importance/Priority, Family 
Responsibilities, Emotional Self-Reliance, and Strength/
Fitness. The five-factor solution was identical to the four-
factor solution except for the Strength/Fitness factor that 
was composed of three items that were the only ones that 
did not load on any factors in the four-factor solution. This 
solution is similar to that reported by Chambers et al. 
(2016) in that the Sexual Importance/Priority, Family 
Responsibilities, and Emotional Self-Reliance factors are 
composed of the same items in each analysis, and Strength/
Fitness included three of the items from the previous 
Strength factor. The novel Optimistic Action factor was 
composed of highest loading items such as: “I am a posi-
tive person” (item 12); “I have a forward thinking mind-
set” (item 16); and “My approach is to get on with things” 
(item 21). As presented in Table 3, the items on this factor 
consist equally of items indicating both an optimistic 
stance and an orientation towards action. The five factors 
were correlated with each other but not excessively so, 
with correlations ranging from 0.1 to 0.53 (see Table 4).
Confirmatory Factor Analysis
The five-factor model was submitted to a CFA on the 
responses of the 311 men in the second, holdout subsam-
ple. Initial inspection of fit indices suggested the model 
did not fit according to conventional criteria (Hu & 
Bentler, 1999; Kline, 2015). χ2 (199) = 520.63, p < .001; 
robust RMSEA = .08 (LO90 = 0.070; HI90 = 0.087); 
robust CFI = .90; robust SRMR = .06. Inspection of 
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Table 1. Sociodemographic Characteristics of Participants 
(N = 622).
Characteristic n (%)
Age (years)
 M (SD) 67.35 (10.05)
 Range 47–93
Education
 Formal schooling not completed 13 (2.1%)
 Completed primary school 146 (23.5%)
 Completed high school 71 (11.4%)
 Trade or technical certificate or 
diploma
267 (42.9%)
 University degree 89 (14.3%)
 Other 22 (3.5%)
 Missing 14 (2.3%)
Employment
 Employed full-time or self-employed 227 (36.5%)
 Employed part-time or casual 48 (7.7%)
 Full-time home duties or home career 6 (1%)
 Unemployed or looking for work 3 (.5%)
 Retired 314 (50.5%)
 Student or volunteering 8 (1.3%)
 Permanently ill/disabled/unable to 
work
4 (.6%)
 Other 9 (1.4%)
 Missing 3 (.5%)
Income
 <$20,000 61 (9.8%)
 $20,000–less than $40,000 149 (24%)
 $40,000–less than $60,000 99 (15.9%)
 $60,000–less than $80,000 76 (12.2%)
 $80,000+ 163 (26.2%)
 Don’t know 26 (4.2%)
Marital status
 Married or de facto 498 (80.1%)
 Divorced or separated 58 (9.3%)
 Widowed 25 (4.0%)
 Never married 24 (3.9%)
 Missing 17 (2.7%)
Children
 One or more children 480 (77.2%)
 No children 79 (12.7%)
Sexual orientation
 Heterosexual 501 (80.5%)
 Homosexual 5 (.8%)
 Bisexual 9 (1.4%)
 Rather not say 12 (1.9%)
 Missing 57 (9.2%)
Ethnicity
 Caucasian 533 (85.7%)
 Asian 3 (.5%)
 European 3 (.5%)
 Aboriginal 1 (.2%)
 Anglo-Indian 2 (.3%)
 Missing 9 (1.4%)
Table 2. Medical Characteristics of Participants (N = 622).
Characteristic n (%)
Weight Classa
 Underweight 1 (.2%)
 Normal weight 90 (14.5%)
 Overweight 267 (42.9%)
 Class 1 obesity 144 (23.2%)
 Class 2 obesity 44 (7.1%)
 Class 3 obesity 11 (1.8%)
 Missing 65 (10.5%)
Comorbidity
 One condition 169 (27.2%)
 Two or more 422 (67.8%)
Cancer
 Skin cancer 78 (12.5%)
 Melanoma 33 (5.3%)
 Bladder cancer 10 (1.6%)
 Prostate cancer 47 (7.6%)
 Bowel cancer 16 (2.6%)
 Kidney cancer 4 (.6%)
 Lung cancer 4 (.6%)
 Non-Hodgkin’s lymphoma 3 (.5%)
 Pancreatic cancer 1 (.2%)
 Other 15 (2.4%)
Health condition
 Heart attack 57 (9.2%)
 Stroke 19 (3.1%)
 Angina 54 (8.7%)
 Transient ischemic attack 15 (2.4%)
 Atrial fibrillation 40 (6.4%)
 Kidney disease 23 (3.7%)
 Hypertension 301 (48.4%)
 Hypercholesterolemia 250 (40.2%)
 Smoking-related lung condition 27 (4.3%)
 Parkinson’s disease 6 (1%)
 Asthma 78 (12.5%)
 Enlarged prostate/benign 
prostatic hyperplasia
118 (19%)
 Diabetes 97 (15.6%)
 Hyper/hypothyroidism 14 (2.2%)
 Osteoarthritis 171 (27.5%)
 Osteoporosis 27 (4.3%)
 Gout 85 (13.7%)
 Anxiety 41 (6.6%)
 Depression 42 (6.8%)
 Insomnia 18 (2.9%)
 A stress-related condition 36 (5.8%)
 None of the above 27 (4.3%)
 Don’t know 6 (1%)
Note. aClassified by BMI: underweight, below 18.49; normal weight, 
18.5–24.9; overweight, 25–29.9; Class 1 obesity, 30–34.9; Class 2 
obesity, 35–39.9; Class 3 obesity, 40 or above.
residuals and modification indices suggested that the 
model did not account for a large number of associations 
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between items within factors. It was deemed that such 
residuals represented method variance shared between 
items tapping into similar domains. Error correlations 
were unconstrained only between within-factor item pairs 
with large residuals. These were between items: 18 and 
14; 7 and 22; 7 and 14; 18 and 22; 12 and 3; 21 and 3; 12 
and 19; 10 and 9; 19 and 9 (see Table 3). The resulting 
model showed excellent fit: χ2 (190) = 326.27; robust 
RMSEA = .052 (LO90 = 0.042; HI90 = 0.061); robust 
CFI = .96; robust SRMR = 0.05. Standardized loadings 
for this analysis are also presented in Table 3.
Discriminant Validity
Correlation analysis showed that the five-factor model 
discriminated between men on the basis of erectile dys-
function and age. Optimistic Action (r = −.16, p < .001), 
Sexual Importance/Priority (r = −.52, p < .001), and 
Table 3. Five-Factor Solution for MCD-I EFA (N = 278) and CFA (N = 311).
Item (Item#) α EFA factor loadings CFA factor loadings
Optimistic Action 0.88  
I am a positive person (12) 0.88 0.72
I have a forward thinking mind-set (16) 0.73 0.81
My approach is to get on with things (21) 0.73 0.78
I am optimistic about the future (19) 0.69 0.71
If I want to achieve something I can (10) 0.69 0.71
I like to take action in the face of problems (6) 0.63 0.63
I always look for the good in situations (3) 0.53 0.54
I am a fighter (9) 0.50 0.60
I am a competitive person (20) 0.45 0.57
Sexual Priority/Importance 0.93  
Being able to have an erection is important to me (5) 0.96 0.92
Being physically able to have sex is important to me (2) 0.89 0.89
I like to know I am capable of having sex (11) 0.88 0.93
Being able to have sex is like being able to run (17) 0.69 0.82
Family Responsibilities 0.89  
It’s up to me to protect my partner or family (22) 0.86 0.89
Being able to provide for my partner or family is important to me (18) 0.88 0.85
I need to provide financial security for my partner or family (14) 0.81 0.84
I like to know I am looking after my partner or family (7) 0.62 0.77
Emotional Self-Reliance 0.68  
I keep my feelings to myself (4) 0.75 0.51
I tend not to talk about my worries (13) 0.83 0.84
Strength/Fitness 0.74  
Having a good level of fitness is important to me (8) 0.85 0.78
Being an active person is important to me (15) 0.60 0.85
Being physically strong is important to me (1) 0.54 0.56
Note. MCD-I = Masculinity in Chronic Disease Inventory, EFA = exploratory factor analysis, CFA = confirmatory factor analysis.
Table 4. Correlations Between MCD-I Subscales and Total Scale (N = 622).
Subscales 1 2 3 4 5 M SD
Optimistic Action − 3.71 0.74
Sexual Importance/Priority 0.30*** − 3.37 1.24
Family Responsibilities 0.51*** 0.27*** − 4.25 0.91
Emotional Self-Reliance 0.22*** 0.10* 0.18*** − 3.47 1.00
Strength/Fitness 0.53*** 0.44*** 0.42*** 0.13** − 3.71 0.86
Total Scale 0.84*** 0.67*** 0.69*** 0.33*** 0.72*** 3.74 0.62
Note. MCD-I = Masculinity in Chronic Disease Inventory.
***p < .001. **p < .01. *p < .05.
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Strength/Fitness (r = −.18, p < .001) all discriminated 
between men with increasing levels of self-reported erec-
tile dysfunction. Similarly, Sexual Importance/Priority 
(r = −.46, p < .001), and Strength/Fitness (r = −.10, 
p = .012) both discriminated between older and younger 
men. Older men and men with self-reported erectile dys-
function had lower masculinity scores on the MCD-I.
Discussion
The present study demonstrates the efficacy and rele-
vance of the MCD-I as an important measure of mascu-
linity for men with chronic disease. The close similarity 
between the factor structure identified in this study 
compared to that reported previously by Chambers et al. 
(2016) shows how sexual well-being, family relation-
ships, physical strength and activity, and an active and 
optimistic approach to life appear central to masculine 
identity for men experiencing chronic disease. From 
this, it can be concluded that this measure is suitable for 
wider application applying the revised five-factor 
model. In line with recommendations by Thompson and 
Bennett (2015), the MCD-I offers a validated tool by 
which to collect empirical evidence about the connec-
tions between masculinities and chronic disease. As 
Oliffe et al. (2019) affirmed, consistent use of validated 
end-user informed masculinity measures is key to bridg-
ing qualitative and quantitative approaches as well as 
transitioning descriptive study findings to inform the 
design and formal evaluation of gender-sensitized men’s 
interventions and services. Further, in light of men’s 
increasing life expectancy in Western countries, and the 
likelihood of men’s chronic disease rates growing in 
step with this trend, there is an ever-pressing need to 
describe and attend to the gendered dimensions of men’s 
illness (and health).
Limitations of this research include the cross-sectional 
study design; however the diverse participant population 
in terms of chronic disease is a strength. There remains a 
need to examine and compare the measurement of mas-
culinity in young men who experience chronic disease 
(i.e., hemophilia, Crohn’s, epilepsy) as well as sexual 
minority men (i.e., gay, bisexual) to gain clarity around 
what aspects of masculinity intersect with chronic disease 
in these subgroups. In addition, an important area of 
future research is to examine how masculinity, as mea-
sured by the MCD-I, relates to health outcomes and 
health-promoting practices as a means to informing the 
design and evaluation of gender-sensitized interventions 
targeting men in the context of chronic disease. For 
example, an instrument such as the MCD-I that assesses 
masculinity as a multidimensional construct can allow 
researchers to assess the role of masculinity in moderat-
ing the effectiveness of interventions with men a priori 
and on a sound theoretical basis, rather than addressing 
post-hoc justifications for unexpected results. This would 
be consistent with the work of Thompson and Barnes 
(2013) who reported marked differences in conceptions 
of sexual performance between men with and without 
erectile dysfunction. In addition, a clearer understanding 
of masculinity scores could aid in targeting important 
health messages, such as those endorsing self-care behav-
iors, to men with chronic illness. Men reporting high 
Emotional Self-Reliance and men reporting high Family 
Responsibilities scores might respond more positively to 
differently framed persuasive health messages.
In conclusion, the MCD-I is a valid measure of inter-
nalized masculine beliefs for men with chronic disease 
that is sensitive to age and to sexual health. The tailoring 
of health services for men in connection to these mascu-
line beliefs is a priority.
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